Triovance presents at 2023 ASGCT Annual Meeting Startup Spotlight

May 17th at 1:00pm
‍

Triovance is honored to be presenting at the Startup Spotlight of the 26th American Society of Gene and Cell Therapy Meeting, scheduled for May 17 th at 1:00 PM. Triovance is dedicated to advancing the field of gene and cell therapies by developing innovative treatments for diabetes and its associated complications. Our team is committed to advancing the science of gene and cell therapies through rigorous research and development, patient-focused clinical trials, and collaboration with leading experts in the field. At the 2023 American Society of Gene and Cell Therapy Annual Meeting, we look forward to sharing our latest research findings. We believe that our cutting-edge gene and cell therapy approach hold great promise for improving the lives of patients with diabetic foot ulcer, and we are excited to be at the forefront of this important field.